Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise over 52 weeks

被引：0
|
作者：
Stenlof, K. [1 ]
Cefalu, W. T. [2 ,3 ,4 ,5 ]
Kim, K. -A. [6 ]
Jodar, E. [7 ]
Alba, M. [8 ]
Edwards, R. [8 ]
Tong, C. [8 ]
Canovatchel, W. [8 ]
Meininger, G. [8 ]
机构：
[1] Sahlgrens Univ Hosp, Clin Trial Ctr, Gothenburg, Sweden
[2] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
[3] LSUHSC Sch Med, Baton Rouge, LA USA
[4] Pennington Biomed Res Ctr, New Orleans, LA USA
[5] LSUHSC Sch Med, New Orleans, LA USA
[6] Dongguk Univ, Sch Med, Ilsan Hosp, Goyang, South Korea
[7] Hosp Quiron, Madrid, Spain
[8] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
935
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
    Stenlof, K.
    Cefalu, W. T.
    Kim, K. -A.
    Alba, M.
    Usiskin, K.
    Tong, C.
    Canovatchel, W.
    Meininger, G.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (04): : 372 - 382
  • [2] Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus inadequately controlled with metformin plus sulphonylurea over 52 weeks
    Vercruysse, F.
    Charpentier, G.
    Wilding, J.
    Hollander, P.
    Gonzalez Galvez, G.
    Mathieu, C.
    Usiskin, K.
    Vijapurkar, U.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 : S373 - S373
  • [3] Efficacy and Safety of Canagliflozin (CANA) Monotherapy in Subjects With Type 2 Diabetes Mellitus (T2DM) Over 52 Weeks
    Stenloef, Kaj
    Cefalu, William T.
    Kim, Kyoung-Ah
    Jodar, Esteban
    Alba, Maria
    Edwards, Robert
    Tong, Cindy
    Canovatchel, William
    Meininger, Gary
    [J]. DIABETES, 2013, 62 : A303 - A303
  • [4] Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus and chronic kidney disease over 52 weeks
    Nieto, J.
    Yale, J. -F.
    Bakris, G.
    Cariou, B.
    Wajs, E.
    Figueroa, K.
    Jiang, J.
    Usiskin, K.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 : S381 - S381
  • [5] Efficacy and Safety of Canagliflozin (CANA) in Japanese Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Diet and Exercise over 24 Weeks
    Inagaki, Nobuya
    Kondo, Kazuoki
    Yoshinari, Toru
    Maruyama, Nobuko
    Takahashi, Nahoko
    Susuta, Yutaka
    Kuki, Hideki
    [J]. DIABETES, 2014, 63 : A266 - A266
  • [6] Efficacy and safety of alogliptin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise
    Mekki, Q.
    Fleck, P.
    Wilson, C.
    DeFronzo, R.
    [J]. DIABETOLOGIA, 2008, 51 : S344 - S344
  • [7] Efficacy and safety of dapaglflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise
    Kaku, K.
    Kiyosue, A.
    Inoue, S.
    Ueda, N.
    Tokudome, T.
    Yang, J.
    Langkilde, A. M.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (11): : 1102 - 1110
  • [8] Efficacy and Safety of Dapagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
    Kaku, Kohei
    Kiyosue, Arihiro
    Inoue, Satoshi
    Ueda, Naohiko
    Tokudome, Takuto
    Yang, Jisin
    Langkilde, Anna Maria
    [J]. DIABETES, 2013, 62 : A303 - A303
  • [9] Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease
    Yale, J. -F.
    Bakris, G.
    Cariou, B.
    Nieto, J.
    David-Neto, E.
    Yue, D.
    Wajs, E.
    Figueroa, K.
    Jiang, J.
    Law, G.
    Usiskin, K.
    Meininger, G.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 1016 - 1027
  • [10] Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
    Terra, Steven G.
    Focht, Kristen
    Davies, Melanie
    Frias, Juan
    Derosa, Giuseppe
    Darekar, Amanda
    Golm, Gregory
    Johnson, Jeremy
    Saur, Didier
    Lauring, Brett
    Dagogo-Jack, Sam
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 721 - 728
12345